TRAP Archive

Sensitive Positron Emission Tomography Imaging of PD-L1 Expression in Human Breast and Lung Carcinoma Xenografts Using the Radiometalated Peptide Ga-68-TRAP-WL12.
Quigley, Neil Gerard, Katja Steiger, Stefanie Felicitas Färber, Frauke Richter, Wilko Weichert, and Johannes Notni. Molecular Pharmaceutics (2024), 21(4), 1827-1837.
… by positron emission tomography (PET) imaging and ex vivo … clinical PD-L1 PET imaging because it detects even very low … The peptide WL12 was purchased from CPC Scientific (San …

Published On: February 5th, 2024Categories: Metal Chelates, Peptide Macrocycles, Unnatural Amino Acids
Learn More

The CPC Scientific website uses cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operations of the website, as well as cookies that are only used for anonymous statistical purposes, for comfort settings or to display personalized content. Please note that based on your settings, it is possible that not all functionalities of the website will be available. You can find further information in our Privacy Policy. Accept Reject

GMP Peptide Manufacturing

Research Peptides

Oligonucleotide Services

Peptide–Oligo Conjugate Services

Specialties

GMP Peptide Manufacturing

Research Peptides

Oligonucleotide Services

Peptide–Oligo Conjugate Services

Specialties

GMP Peptide Manufacturing

Research Peptides

Oligonucleotide Services

Peptide–Oligo Conjugate Services

Specialties

GMP Peptide Manufacturing

Research Peptides

Oligonucleotide Services

Peptide–Oligo Conjugate Services

Specialties

TRAP Archive

Sensitive Positron Emission Tomography Imaging of PD-L1 Expression in Human Breast and Lung Carcinoma Xenografts Using the Radiometalated Peptide Ga-68-TRAP-WL12.

Title